Description: Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical is headquartered in Tianjin City, the People's Republic of China.
1801 Guangyin Building
Tianjin City,
300074
China
Phone:
86 22 2337 0440
Officers
| Name | Title |
|---|---|
| Mr. Fuzhi Song | Chairman, Chief Exec. Officer, Pres and Chairman of Zhongjin Biology Devel. Co. Ltd |
| Mr. Shuli Zhang CPA, CPV, CTA | CFO, Principal Accounting Officer, Treasurer and CFO of Zhongjin |
| Ms. Sufen Ail | Sec. |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.0753 |
| Price-to-Sales TTM: | 0.0342 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 86 |